Meag Munich Ergo’s Carlyle Group CG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,890
Closed -$355K 189
2022
Q4
$355K Hold
11,890
0.02% 190
2022
Q3
$307K Sell
11,890
-16,049
-57% -$528K 0.02% 184
2022
Q2
$885K Sell
27,939
-38,870
-58% -$1.49M 0.05% 150
2022
Q1
$3.31M Buy
66,809
+28,060
+72% +$1.34M 0.24% 82
2021
Q4
$2.11M Buy
+38,749
New +$2.11M 0.15% 93
2021
Q3
Sell
-4,401
Closed -$205K 236
2021
Q2
$205K Sell
4,401
-26,813
-86% -$1.14M 0.02% 312
2021
Q1
$1.15M Sell
31,214
-57,211
-65% -$2.01M 0.12% 164
2020
Q4
$2.78M Buy
88,425
+27,212
+44% +$766K 0.64% 49
2020
Q3
$1.51M Buy
+61,213
New +$1.65M 0.28% 92

Other funds holding CG

Meag Munich Ergo's CG Position: Q1 2023 in Review

Meag Munich Ergo sold out of Carlyle Group (CG) in Q1 2023, closing a stake of 11,890 shares — an estimated $355K sold.

Meag Munich Ergo first reported a position in CG in Q3 2020 and held it in 9 quarters. The position peaked at $3.31M in Q1 2022. 430 funds tracked by Wall St. Rank hold CG as of Q1 2023.

  • Meag Munich Ergo reported no remaining Carlyle Group position as of Q1 2023 after selling out during the quarter.
  • Meag Munich Ergo sold 11,890 Carlyle Group shares in Q1 2023, an estimated $355K.
  • Meag Munich Ergo first reported a position in Carlyle Group in Q3 2020 and held it in 9 quarters.
  • Meag Munich Ergo's Carlyle Group position peaked at $3.31M in Q1 2022.
  • 430 funds tracked by Wall St. Rank held Carlyle Group as of Q1 2023.

Based on Meag Munich Ergo's 13F filing for Q1 2023, filed 20 Apr 2023.